Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07218198 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Decision Support Tool for the Treatment of Uncontrolled Hypertension

Study acronym: AI-HTN
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later Jul 1, 2027 → Jan 2028
See other at-risk trials from The Cleveland Clinic

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 1, 2027 to Jan 2028 Show 6 more changesShow less
    • Start date: Jul 1, 2026 to Jan 2027
    • Study completion pushed from Dec 1, 2027 to Jun 2028
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site contact updated
    • Publications: details revised at 3 of 3 entries
  2. Start date: May 1, 2026 to Jul 1, 2026
    • Primary completion pushed from May 1, 2027 to Jul 1, 2027
    • Study completion pushed from Oct 1, 2027 to Dec 1, 2027
    v4
  3. Start date: Apr 1, 2026 to May 1, 2026
    • Primary completion date: Apr 1, 2027 to May 1, 2027
    v3
  4. Start date: Dec 1, 2025 to Apr 1, 2026
    • Primary completion date: Dec 1, 2026 to Apr 1, 2027
    • Study completion date: Jun 1, 2027 to Oct 1, 2027
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to study whether having a clinical decision support (CDS) tool available to clinician use will more effectively lower BP 4 weeks after an outpatient visit compared with usual care. The main objective is to assess the impact of the CDS tool, that is embedded with the electronic medical record (EMR), that is available during outpatient clinical encounters, on blood pressure (BP) changes among participants with uncontrolled hypertension. Participants will: Visit the clinic 4 weeks, after their initial clinician visit, for a BP check.
Trial Details
NCT Number NCT07218198
Lead Sponsor The Cleveland Clinic
Conditions
(from sponsor)		 Hypertension, Hypertension (HTN), Blood Pressure, High, Blood Pressure Control
Related terms Hypertension
Enrollment 168 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov